← Back to Search

Gait Retraining for Osteoarthritis

N/A
Recruiting
Led By Nelson Cortes
Research Sponsored by George Mason University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to walk unaided for a minimum of 20 minutes
a clinical diagnosis of knee osteoarthritis by a qualified health professional such as an orthopedic surgeon or physical therapist
Must not have
Cognitive impairment that would inhibit motor learning
Neurological or musculoskeletal conditions affecting ambulation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up it will be assessed using biomechanical analysis at baseline and 10-weeks gait retraining intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will investigate whether gait retraining can reduce frontal plane knee moment in people with tibiofemoral joint osteoarthritis, and assess the effects on the biomechanics of the contralateral side.

Who is the study for?
This trial is for adults aged 18-80 with knee osteoarthritis, who can walk unaided for at least 20 minutes. It's not suitable for those with a BMI over 35, recent back or leg surgery, knee treatments in the last six months, conditions affecting walking, cognitive impairments impacting motor learning, or if they use gait aids or certain orthotics.
What is being tested?
The study tests how changing the way participants walk (foot progression and trunk lean) affects their knee mechanics and pain. Participants will be split into groups to either receive tailored gait retraining or continue normal walking as a control group. The training includes eight sessions with decreasing feedback on their steps.
What are the potential side effects?
While specific side effects are not listed for this type of physical therapy intervention, participants may experience discomfort or muscle fatigue due to new walking patterns during gait retraining.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk by myself for at least 20 minutes.
Select...
I have been diagnosed with knee osteoarthritis by a healthcare professional.
Select...
I am between 18 and 80 years old.
Select...
I have been diagnosed with knee osteoarthritis by a healthcare professional.
Select...
I am between 18 and 80 years old.
Select...
I can walk by myself for at least 20 minutes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any cognitive issues that affect my ability to learn new physical tasks.
Select...
I have a condition that affects my ability to walk.
Select...
I use a walking aid, shoe inserts, or a knee brace.
Select...
I have not had lower back, hip, or knee surgery in the last 2 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~it will be assessed using biomechanical analysis at baseline and 10-weeks gait retraining intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and it will be assessed using biomechanical analysis at baseline and 10-weeks gait retraining intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline Knee Adduction Moment from Baseline at 10-weeks

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Trunk LeanExperimental Treatment1 Intervention
Participants will visualize a desired trunk lean angle bandwidth in real-time that they should target with their trunk lean angle
Group II: Foot ProgressionExperimental Treatment1 Intervention
Participants will visualize a desired foot progression angle bandwidth in real-time that they should target with their foot angle
Group III: ControlActive Control1 Intervention
No intervention

Find a Location

Who is running the clinical trial?

George Mason UniversityLead Sponsor
58 Previous Clinical Trials
48,737 Total Patients Enrolled
Nelson CortesPrincipal InvestigatorAssociate Professor

Media Library

Gait Retraining Clinical Trial Eligibility Overview. Trial Name: NCT03663790 — N/A
Osteoarthritis Research Study Groups: Control, Foot Progression, Trunk Lean
Osteoarthritis Clinical Trial 2023: Gait Retraining Highlights & Side Effects. Trial Name: NCT03663790 — N/A
Gait Retraining 2023 Treatment Timeline for Medical Study. Trial Name: NCT03663790 — N/A
~11 spots leftby Oct 2026